Cardiovascular risk factors in football players

Current Sports Medicine Reports

Volumn 10, Issue 6, 2011, Pages 378-382

  Dixit, Sameer ^a   Hecht, Suzanne ^b   Concoff, Andrew ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c Outpatient Musculoskeletal Rehabilitation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; C REACTIVE PROTEIN; CHOLESTEROL; HOMOCYSTEINE; INSULIN; LIPID;

ARTICLE; ATHLETE; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIET THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; FOOTBALL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; MORTALITY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PATIENT PARTICIPATION; PHYSICAL ACTIVITY; PREHYPERTENSION; PREVALENCE; SEDENTARY LIFESTYLE; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; WAIST HIP RATIO; WEIGHT CONTROL;

ATHLETES; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FOOTBALL; HUMANS; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; MALE; OBESITY; PREHYPERTENSION; RISK FACTORS; SEDENTARY LIFESTYLE; UNITED STATES; WAIST-HIP RATIO;

EID: 82955165800     PISSN: 1537890X     EISSN: 15378918     Source Type: Journal    
DOI: 10.1249/JSR.0b013e31823a362e     Document Type: Article

References (54)

1. Albert MA, Glynn RJ, Ridker PM. Effect of physical activity on serum Creactive protein. Am. J. Cardiol. 2004; 93:221-5. (Pubitemid 38058737)
2. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 2006; 23:469-80.
3. American Heart Association. Executive summary: Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation. 2011; 123:459-63.
4. Baron S, Rinsky R. NIOSH Mortality Study of NFL Football Players 1959-1988. Cincinnati (OH): Center for Disease Control, National Institute of Occupational Safety and Health; 1994.
5. Bogers RP, Bemelmans WJ, Hoogenveen RT, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: A meta-analysis of 21 cohort studies including more than 300 000 persons. Arch. Intern. Med. 2007; 167:1720-8. (Pubitemid 47403058)
6. Borrione P, Pigozzi F, Massazza G, et al. Hyperhomocysteinemia in winter elite athletes: A longitudinal study. J. Endocrinol. Invest. 2007; 30:367-75. (Pubitemid 47098231)
7. Borrione P, Rizzo M, Spaccamiglio A, et al. Sport-related hyperhomocysteinaemia: A putative marker for muscular demand to be noticed for cardiovascular risk. Br. J. Sports Med. 2008; 42:894-900.
8. Brownbill RA, Ilich JZ. Measuring body composition in overweight individuals by dual energy x-ray absorptiometry. BMC Med. Imaging. 2005; 5:1.
9. Centers for Disease Control and Prevention [Internet]. Leading causes of death; [cited 2011 June 13]. Available from: Http://www.cdc.gov/ nchs/fastats/lcod.htm.
10. Chambers JC, Seddon MD, Shah S, Kooner JS. HomocysteineV a novel risk factor for vascular disease. J. R. Soc. Med. 2001; 94:10-3. (Pubitemid 32116138)
11. Dufaux B, Order U, Geyer H, Hollmann W. C-reactive protein serum concentrations in well-trained athletes. Int. J. Sports Med. 1984; 5: 102-6. (Pubitemid 14104344)
12. Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Executive summary of clinical guidelines for identification, evaluation and treatment of overweight and obesity in adults. Arch. Intern. Med. 1998; 158:1855-67.
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-97.
14. Garry JP, McShane JJ. Analysis of lipoproteins and body mass index in professional football players. Prev. Cardiol. 2001; 4:103-8. (Pubitemid 32618732)
15. George CF, Kab V, Levy AM. Increased prevalence of sleep-disordered breathing among professional football players. N. Engl. J. Med. 2003; 348:367-8. (Pubitemid 36120002)
16. Graham MR, Grace FM, Boobier W, et al. Homocysteine induced cardiovascular events: A consequence of long term anabolicYandrogenic steroid (AAS) abuse. Br. J. Sports Med. 2006; 40:644-8. (Pubitemid 44032655)
17. Harp JB, Hecht L. Obesity in the National Football League. JAMA. 2005; 293:1061-2.
18. Hermann M, Schorr H, Obeid R, et al. Homocysteine increases during endurance exercise. Clin. Chem. Lab. Med. 2003; 41:1518-24. (Pubitemid 37493570)
19. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67:968-77. (Pubitemid 13080473)
20. Kasier GE, Womack JW, Green JS, et al. Morphological profiles for firstyear National Collegiate Athletic Association Division I football players. J. Strength Cond. Res. 2008; 22:243-9.
21. Khot UN, Khot MB, Baizer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003; 290: 898-904. (Pubitemid 37430461)
22. Kraemer WJ, Torine JC, Silvestre R, et al. Body size and composition of National Football League players. J. Strength Cond. Res. 2005; 19: 485-9. (Pubitemid 41305858)
23. LaMonte MJ, Durstine JL, Yanowitz FG, et al. Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of women. Circulation. 2002; 106:403-6. (Pubitemid 34803681)
24. Laurson KR, Eisenmann JC. Prevalence of overweight among high school football linemen. JAMA. 2007; 297:363-4. (Pubitemid 46155797)
25. Lynch NA, Ryan AS, Evans J, et al. Older elite football players have reduced cardiac and osteoporosis risk factors. Med. Sci. Sports Exerc. 2007; 39:1124-30. (Pubitemid 47014141)
26. Malnick SD, Knobler H. The medical complications of obesity. QJM. 2006; 99:566-79.
27. Mather KJ, Hunt AE, Steinberg HO, et al. Repeatability characteristics of simple indices of insulin resistance: Implications for research applications. J. Clin. Endocrinol. Metab. 2001; 86:5457-64. (Pubitemid 33070275)
28. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412-9. (Pubitemid 15018832)
29. Miller MA, Croft LB, Belanger AR, et al. Prevalence of metabolic syndrome in retired National Football League players. Am. J. Cardiol. 2008; 101:1281-4.
30. Nicholas SJ, Nicholas JA, Nicholas C, et al. The health status of retired American football players: Super Bowl III revisited. Am. J. Sports Med. 2007; 35:1674-9. (Pubitemid 47476047)
31. Nieto FJ, Young TB, Link BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000; 283:1829-36. (Pubitemid 30207619)
32. Ode JJ, Pivarnik MJ, Reeves MJ, Knous JL. Body mass index as a predictor of percent fat in college athletes and nonathletes. Med. Sci. Sports Exerc. 2007; 39:403-9. (Pubitemid 46667938)
33. Okura T, Rankinen T, Gagnon J. Effect of regular aerobic exercise on plasma homocysteine concentrations: The HERITAGE Family Study. Med. Sci. Sports Exerc. 2004; 36:S188-9.
34. Pearson TA, Mensah GA. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003; 107:499-511. (Pubitemid 36158056)
35. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med. 2000; 342:1378-84. (Pubitemid 30262394)
36. Pitsavos C, Chrysohoou C, Panagiotakos DB, et al. Association of leisure-time physical activity on inflammation markers (C-reactive protein, white blood cell count, serum amyloid A, and fibrinogen) in healthy subjects (from the ATTICA study). Am. J. Cardiol. 2003; 91:369-70.
37. Plaisance EP, Grandjean PW. Physical activity and high-sensitivity C-reactive protein. Sports Med. 2006; 36:443-58.
38. Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog. Horm. Res. 2004; 59:207-23. (Pubitemid 41327152)
39. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 1997; 336:973-9. (Pubitemid 27152782)
40. Ridker PM, Glynn RJ, Hennekens CH, et al. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998; 97:2007-11. (Pubitemid 28243661)
41. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 2002; 347:1557-66.
42. Root M, Cobb F. Traditional risk factors for coronary heart disease. JAMA. 2004; 291:299. Letter.
43. Sadeghian S, Fallahi F, Salarifar M, et al. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc. Disord. 2006; 6:38.
44. Segal KR, Dunaif A, Gutin B, et al. Body composition, not body weight, is related to cardiovascular disease risk factors and sex hormone levels in men. J. Clin. Invest. 1987; 80:1050-55. (Pubitemid 18075641)
45. Snow TK, Millard-Stafford M, Rosskopf LB. Body composition profile of NFL football players. J. Strength Cond. Res. 1998; 12:146-9.
46. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003; 289:2560-72.
47. Tucker A, Vogel RA, Lincoln AE, et al. Prevalence of cardiovascular disease risk factors among National Football League players JAMA. 2009; 301:2111-9.
48. Wei M, Kampert JB, Barlow CE, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA. 1999; 282:1547-53. (Pubitemid 29504048)
49. Wierzbicki AS. Homocysteine and cardiovascular disease: A review of the evidence. Diab. Vasc. Dis. Res. 2007; 4:143-9. (Pubitemid 47178770)
50. Wilkerson GB, Bullard JT, Bartal DW. Identification of cardiometabolic risk among collegiate football players. J. Athl. Train. 2010; 45:67-74.
51. Wright M, Francis K, Cornwell P. Effect of acute exercise on plasma homocysteine. J. Sports Med. Phys. Fitness. 1998; 38:262-5. (Pubitemid 28530153)
52. Yalow RS, Berson SA. Immunoassay of endogenous insulin in man. J. Clin. Invest. 1960; 39:1157-75.
53. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J. Clin. Endocrinol. Metab. 1998; 83:2773-6. (Pubitemid 28493774)
54. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: A case-control study. Lancet. 2005; 366:1640-9. (Pubitemid 41552419)